Patented microchannel heat-exchange technology enables the production of hydrogen from methane, the main ingredient of natural gas, while producing 30 percent less carbon dioxide than conventional processes.
Gosline works to develop computational algorithms that are uniquely targeted for rare disease work by doing foundational research in model system development. This work can be expanded to all model systems in human disease.
PNNL is working with the Port of Seattle and Seattle City Light to assess the risks of long-term hydrogen storage that can bring clean power for decarbonization.
Data-driven autonomous technology to rapidly design and deliver antiviral interventions targeting SARS-CoV-2 to reduce drug discovery timeline and advance bio preparedness capabilities.
New research findings published in Science Advances (November 2022), help explain the progression of Alzheimer-related dementia in each patient. The findings outline a biological classification system that predicts disease severity.
A PNNL team developed and used a model framework to understand the performance and structural reliability of a state-of-the-art solid oxide electrolysis cell design.
Morris Bullock has led PNNL's pursuit of the efficient conversion of electrical energy and chemical bonds through control of electron and proton transfers.